Clinical Trials Logo

Myotonic Disorders clinical trials

View clinical trials related to Myotonic Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05479981 Active, not recruiting - Clinical trials for Nervous System Diseases

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

MARINA-OLE
Start date: August 4, 2022
Phase: Phase 2
Study type: Interventional

AOC 1001-CS2 (MARINA-OLE) is a Phase 2 extension of the AOC 1001-CS1 (MARINA) study to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple-doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) patients

NCT ID: NCT04622553 Active, not recruiting - Myotonic Disorders Clinical Trials

Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.

Start date: November 5, 2021
Phase: N/A
Study type: Interventional

Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in Paediatric Patients with Myotonic Disorders Who Have Completed the MEX-NM-301 study.

NCT ID: NCT04616807 Active, not recruiting - Myotonic Dystrophy Clinical Trials

An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders

Start date: December 17, 2020
Phase:
Study type: Observational

This is a non-interventional, prospective, observational, multicentre study to evaluate the long-term safety and effectiveness of Namuscla in adult patients with NDM.